AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Clinical trials for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE explained in plain language.
Never miss a new study
Get alerted when new AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE trials appear
Sign up with your email to follow new studies for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for calming Alzheimer's agitation
Symptom relief CompletedThis study tested whether the medication AXS-05 could safely reduce agitation in people with Alzheimer's disease. 408 participants with Alzheimer's-related agitation were randomly assigned to receive either the drug or a placebo for 5 weeks. Researchers measured changes in agitat…
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New Alzheimer's agitation treatment shows promise in major trial
Symptom relief CompletedThis study tested whether AXS-05 is safe and effective for reducing agitation in people with Alzheimer's disease over a long period. 456 participants who had already shown benefit from AXS-05 in previous studies were either kept on the medication or switched to placebo to see if …
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 16, 2026 15:23 UTC